The gold standard treatment for type 1 diabetes mellitus is intensive insulin replacement. An alternative approach is to suppress the autoimmune reaction against pancreatic β-cells; this ...

In addition to treating Type 1 diabetes, this technique could open the door for the treatment of other autoimmune conditions. Many experts already see a future in which stem cell therapy is ...

In my work as a diabetes researcher, my colleagues and I have found that making islets from stem cells can help overcome transplantation challenges. Islet transplantation for Type 1 diabetes was ...

announced promising results of a revolutionary advancement in the management of diabetes, successfully performing umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy for a 20-year old ...

A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

One of the most exciting developments in diabetes treatment is the use of new medications that help control blood sugar in ...

A completely new way of treating type 1 diabetes is being tested at Uppsala ... solved in the last ten years by means of a type of stem cell treatment with insulin-producing cells that is ...

Induced Pluripotent Stem Cells (iPSCs)), By Diabetes Type (Type 1 Diabetes, Type 2 Diabetes), By Application (Pancreatic Islet Transplantation, Insulin-Producing Cell Therapy, Gene Therapy), By ...

Mesenchymal stem cells have the ability to self-renew and can differentiate into a variety of cell types. MSCs can be isolated from a variety of tissues, such as umbilical cord. The treatment was ...

announced promising results of a revolutionary advancement in the management of diabetes, successfully performing umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy for a 20-year-old ...

Some studies reported sustained benefits for up to 36 months after the stem cell infusion Versatile Application: The therapy shows promise for both Type 1 and Type 2 diabetes, as well as diabetes ...